These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16810467)

  • 41. Older age should not be a barrier to the treatment of hypertension.
    Aronow WS
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Belgian global implementation of cardiovascular and stroke risk assessment study: methods and baseline data of the BELGICA-STROKE STUDY.
    Van der Niepen P; Thijs V; Devroey D; Fieuw A; Dramaix M; Van de Borne P
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):635-41. PubMed ID: 21450634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [ESH/ESC 2003].
    Umemura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():562-8. PubMed ID: 16981591
    [No Abstract]   [Full Text] [Related]  

  • 44. [Blood pressure: the lower the better? Maybe yes].
    Verdecchia P; Angeli F; Aita A; Bartolini C; Garofoli M; Reboldi G
    G Ital Cardiol (Rome); 2016 May; 17(5):335-8. PubMed ID: 27310905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments.
    Simpson FO
    J Hypertens; 1997 Jan; 15(1):1-2. PubMed ID: 9050964
    [No Abstract]   [Full Text] [Related]  

  • 46. [When is blood pressure lowering needed?].
    Tikkanen I; Tikkanen T
    Duodecim; 1999; 115(8):945-9. PubMed ID: 11859528
    [No Abstract]   [Full Text] [Related]  

  • 47. [Blood pressure: the lower the better? Maybe no].
    Parretti D; Parretti L; Medolla A
    G Ital Cardiol (Rome); 2016 May; 17(5):339-42. PubMed ID: 27310906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
    Bejan-Angoulvant T; Saadatian-Elahi M; Wright JM; Schron EB; Lindholm LH; Fagard R; Staessen JA; Gueyffier F
    J Hypertens; 2010 Jul; 28(7):1366-72. PubMed ID: 20574244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ANBP-2].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():414-8. PubMed ID: 16981572
    [No Abstract]   [Full Text] [Related]  

  • 50. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Module 1: Historical review of evidence-based treatment of hypertension.
    White WB
    J Fam Pract; 2012 Aug; 61(8 Suppl):S5-14; quiz S27. PubMed ID: 22993740
    [No Abstract]   [Full Text] [Related]  

  • 52. Diet and the prevention of cardiovascular diseases.
    Paradis G; Fodor JG
    Can J Cardiol; 1999 Dec; 15 Suppl G():81G-8G. PubMed ID: 10692664
    [No Abstract]   [Full Text] [Related]  

  • 53. Establishing the effect of antihypertensive treatment on coronary morbidity and mortality.
    Wilhelmsen L
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():41-6; discussion 47. PubMed ID: 2691694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor adherence to antihypertensive drugs.
    BMJ; 2016 Oct; 355():i5606. PubMed ID: 27754838
    [No Abstract]   [Full Text] [Related]  

  • 55. [Threshold and target blood pressures for treating hypertension. The facts].
    Holzgreve H
    MMW Fortschr Med; 2005 Apr; 147(15):45-6. PubMed ID: 15884503
    [No Abstract]   [Full Text] [Related]  

  • 56. Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage.
    Zanchetti A
    Blood Press; 1992 Dec; 1(4):205-11. PubMed ID: 1345217
    [No Abstract]   [Full Text] [Related]  

  • 57. Will ASCOT change the form of anti-hypertensive therapy?
    Bilous R
    Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of hypertension in diabetic patients: outstanding issues.
    Camafort-Babkowski M; Barrios V; Coca A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):721-8. PubMed ID: 21714603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationships of different types of event to cardiovascular death in trials of antihypertensive treatment: an aid to definition of total cardiovascular disease risk in hypertension.
    Zambon A; Arfè A; Corrao G; Zanchetti A
    J Hypertens; 2014 Mar; 32(3):495-508. PubMed ID: 24378997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.